In conclusion, this report provides an excellent starting platform for designing and optimizing potent and selective ChAT ligands, with high potential as PET-imaging probe for early diagnosis of AD, and related dementias, such as Down’s syndrome and Lewy body disorders. This evidence concerns the gene CHAT and Alzheimer disease.